Role of perilesional edema and tumor volume in the prognosis of non-small cell lung cancer (NSCLC) undergoing radiosurgery (SRS) for brain metastases

2019 ◽  
Vol 195 (8) ◽  
pp. 734-744 ◽  
Author(s):  
Valerio Nardone ◽  
Sara Nanni ◽  
Pierpaolo Pastina ◽  
Claudia Vinciguerra ◽  
Alfonso Cerase ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Brain Metastases ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Tumor Volume ◽  
Small Cell ◽  
Small Cell Lung ◽  
Perilesional Edema

What is the role of palliative chemotherapy in metastatic non small cell lung cancer with brain metastases?

Lung Cancer ◽  
2008 ◽  
Vol 60 ◽  
pp. S29
Author(s):  
Q. Ghafoor ◽  
D.W.Y. Wong ◽  
L. Capaldi ◽  
S. Collins ◽  
A. El-Modir ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Brain Metastases ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Palliative Chemotherapy ◽  
Small Cell ◽  
Small Cell Lung

What is the role of palliative chemotherapy in metastatic non small cell lung cancer with brain metastases?

Lung Cancer ◽  
2008 ◽  
Vol 60 ◽  
pp. S22
Author(s):  
Q. Ghafoor ◽  
D.W.Y. Wong ◽  
L. Capaldi ◽  
A. Collins ◽  
A. El-Modir ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Brain Metastases ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Palliative Chemotherapy ◽  
Small Cell ◽  
Small Cell Lung

scholarly journals P2-257: The role of palliative chemotherapy in metastatic non small cell lung cancer with brain metastases

2007 ◽  
Vol 2 (8) ◽  
pp. S675
Author(s):  
Daniel W. Wong ◽  
Paul Sanghera ◽  
Qamar Ghafoor ◽  
Jas Kaur ◽  
Philippa Howlett ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Brain Metastases ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Palliative Chemotherapy ◽  
Small Cell ◽  
Small Cell Lung

scholarly journals The role of microRNA-21 in predicting brain metastases from non-small cell lung cancer

2016 ◽  
Vol Volume 10 ◽  
pp. 185-194 ◽  
Author(s):  
Jing Dong ◽  
Zhi Zhang ◽  
Tao Gu ◽  
Shu-Feng Xu ◽  
Li-Xin Dong ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Brain Metastases ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung

scholarly journals PET-Based Volumetric Biomarkers for Risk Stratification of Non-Small Cell Lung Cancer Patients

Diagnostics ◽  
2021 ◽  
Vol 11 (2) ◽  
pp. 210
Author(s):  
Sara Pellegrino ◽  
Rosa Fonti ◽  
Alessandro Pulcrano ◽  
Silvana Del Vecchio
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Cancer Biology ◽  
Tumor Volume ◽  
Tnm Staging ◽  
Small Cell ◽  
Small Cell Lung ◽  
Nsclc Patients

Despite the recent advances in lung cancer biology, molecular pathology, and treatment, this malignancy remains the leading cause of cancer-related death worldwide and non-small cell lung cancer (NSCLC) is the most common form found at diagnosis. Accurate staging of the disease is a fundamental prognostic factor that correctly predicts progression-free (PFS) and overall survival (OS) of NSCLC patients. However, outcome of patients within each TNM staging group can change widely highlighting the need to identify additional prognostic biomarkers to better stratify patients on the basis of risk. 18F-FDG PET/CT plays an essential role in staging, evaluation of treatment response, and tumoral target delineation in NSCLC patients. Moreover, a number of studies showed the prognostic role of imaging parameters derived from PET images, such as metabolic tumor volume (MTV) and total lesion glycolysis (TLG). These parameters represent three-dimensional PET-based measurements providing information on both tumor volume and metabolic activity and previous studies reported their ability to predict OS and PFS of NSCLC patients. This review will primarily focus on the studies that showed the prognostic and predictive role of MTV and TLG in NSCLC patients, addressing also their potential utility in the new era of immunotherapy of NSCLC.

Sign in / Sign up

Export Citation Format

Share Document